This site is new - feedback and suggestions welcome via GitHub issues.

#glioblastoma — Saturday, September 05, 2026 (1 items)

0 ℹ Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial. (nature.com) robot Sun L … Wen PY Nature Communications 2026-09-05 #immunotherapy #glioblastoma #neoadjuvant #checkpoint-inhibitors #clinical trial